Identifying Molecular Markers of Relapse in Myelodysplastic Syndrome
In this month's installment of Ask the PI, ONCOLOGY spoke with Meagan A. Jacoby, MD, PhD, and Matthew Walter, MD, about their findings and what they might mean for practicing oncologists.
POINT-Prostate Cancer Genomic Analysis: Routine or Research Only?
In this side of the Point/Counterpoint, Drs. Bernard and Flaig state that genomic testing should be routine in the management of prostate cancer patients.
COUNTERPOINT-Prostate Cancer Genomic Analysis: Routine or Research Only?
In this side of the Point/Counterpoint, Drs. Kelly and Knudsen state that limitations exist for guiding therapeutic treatment with genomic testing in prostate cancer patients.
